Gland Pharma Limited (BOM:543245)

Aspen Technology Revenue

Gland Pharma had revenue of 15.06B INR in the quarter ending June 30, 2025, with 7.41% growth. This brings the company's revenue in the last twelve months to 57.20B, down -2.34% year-over-year. In the fiscal year ending March 31, 2025, Gland Pharma had annual revenue of 56.17B, down -0.85%.

• Revenue (ttm): 57.20B
• Revenue Growth: -2.34%
• P/S Ratio: 5.64
• Revenue / Employee: 13.15M
• Employees: 4,286
• Market Cap: 322.51B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	56.17B	-482.18M	-0.85%
Mar 31, 2024	56.65B	20.40B	56.29%
Mar 31, 2023	36.25B	-7.76B	-17.64%
Mar 31, 2022	44.01B	9.38B	27.08%
Mar 31, 2021	34.63B	8.30B	31.51%